- Home
- ETON vs DIBS Comparison
ETON vs DIBS Comparison
Compare ETON & DIBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- DIBS
- Stock Information
- Founded
- ETON 2017
- DIBS 2000
- Country
- ETON United States
- DIBS United States
- Employees
- ETON N/A
- DIBS N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- DIBS Catalog/Specialty Distribution
- Sector
- ETON Health Care
- DIBS Consumer Discretionary
- Exchange
- ETON Nasdaq
- DIBS Nasdaq
- Market Cap
- ETON 199.5M
- DIBS 175.8M
- IPO Year
- ETON 2018
- DIBS 2021
- Fundamental
- Price
- ETON $12.44
- DIBS $3.57
- Analyst Decision
- ETON Strong Buy
- DIBS Buy
- Analyst Count
- ETON 2
- DIBS 2
- Target Price
- ETON $15.00
- DIBS $8.00
- AVG Volume (30 Days)
- ETON 236.0K
- DIBS 200.9K
- Earning Date
- ETON 11-12-2024
- DIBS 11-08-2024
- Dividend Yield
- ETON N/A
- DIBS N/A
- EPS Growth
- ETON N/A
- DIBS N/A
- EPS
- ETON N/A
- DIBS N/A
- Revenue
- ETON $34,677,000.00
- DIBS $86,409,000.00
- Revenue This Year
- ETON $23.05
- DIBS $5.17
- Revenue Next Year
- ETON $81.27
- DIBS $7.90
- P/E Ratio
- ETON N/A
- DIBS N/A
- Revenue Growth
- ETON 5.64
- DIBS N/A
- 52 Week Low
- ETON $3.03
- DIBS $3.37
- 52 Week High
- ETON $13.98
- DIBS $6.30
- Technical
- Relative Strength Index (RSI)
- ETON 65.21
- DIBS 42.22
- Support Level
- ETON $11.64
- DIBS $3.69
- Resistance Level
- ETON $13.01
- DIBS $3.79
- Average True Range (ATR)
- ETON 0.76
- DIBS 0.15
- MACD
- ETON -0.10
- DIBS 0.01
- Stochastic Oscillator
- ETON 50.43
- DIBS 52.59
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The company's single reportable and operating segment contains two reporting units; 1stDibs, which consists of the company's online marketplace that enables commerce between sellers and buyers; and Design Manager, which is the company's separate online platform that is used to sell a software solution to interior designers. It generates revenue primarily from fees from seller marketplace services as well as other services, including advertisements and software services.